Noxxon Pharma Raises €33 Million
Noxxon Pharma AG, a German developer of biostable aptamers, has raised €33 million in Series D funding. NGN Capital led the round, and was joined by return backers TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow Venture Capital, FCP OP MEDICAL BioHealth-Trends, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH and the Dieckell Group. Noxxon raised a €37 million Series C round in May 2007.
27 May 2010•5 mins read
